123 related articles for article (PubMed ID: 7495359)
21. Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.
Kimbi HK; Fagbenro-Beyioku AF
East Afr Med J; 1996 Oct; 73(10):634-5. PubMed ID: 8997840
[TBL] [Abstract][Full Text] [Related]
22. The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation--artemisinin or artesunate with long-acting blood schizontocides.
Peters W; Robinson BL
Ann Trop Med Parasitol; 2000 Jan; 94(1):23-35. PubMed ID: 10723521
[TBL] [Abstract][Full Text] [Related]
23. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis.
Singh N; Puri SK
Acta Trop; 2000 Nov; 77(2):185-93. PubMed ID: 11080509
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
Biot C; Glorian G; Maciejewski LA; Brocard JS
J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
[TBL] [Abstract][Full Text] [Related]
25. The chemotherapy of rodent malaria. XLIV. Studies on the mode of action of CM 6606, an indolo (3,2-c) quinoline N-oxide.
Peters W; Robinson BL; Mutambu SL; Warhurst DC; Ellis DS; Tovey DG
Ann Trop Med Parasitol; 1989 Feb; 83(1):1-10. PubMed ID: 2688575
[TBL] [Abstract][Full Text] [Related]
26. Comparison of effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on rodent malaria.
Shao BR; Ye XY; Chu YH
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):59-63. PubMed ID: 1523480
[TBL] [Abstract][Full Text] [Related]
27. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1997 Mar; 91(2):141-5. PubMed ID: 9307655
[TBL] [Abstract][Full Text] [Related]
28. An Alternative Autophagy-Related Mechanism of Chloroquine Drug Resistance in the Malaria Parasite.
Kamil M; Atmaca HN; Unal S; Kina UY; Burak P; Deveci G; Yilmaz I; Aly ASI
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0026922. PubMed ID: 36342168
[TBL] [Abstract][Full Text] [Related]
29. The chemotherapy of rodent malaria, XXXVII. The in vivo action of two Mannich bases, WR 194,965 and WR 228,258 and an 8-aminoquinoline WR 225,448.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):561-5. PubMed ID: 6532327
[TBL] [Abstract][Full Text] [Related]
30. The chemotherapy of rodent malaria XLI. Causal prophylaxis. Part V. Effect of mefloquine on exoerythrocytic schizogony in Plasmodium yoelii yoelii.
Boulard Y; Landau I; Miltgen F; Peters W; Ellis DS
Ann Trop Med Parasitol; 1986 Dec; 80(6):577-80. PubMed ID: 3499879
[TBL] [Abstract][Full Text] [Related]
31. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
[TBL] [Abstract][Full Text] [Related]
32. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
33. The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance.
Peters W; Robinson BL; Ellis DS
Ann Trop Med Parasitol; 1987 Oct; 81(5):639-46. PubMed ID: 3331253
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of chiral chloroquine and its analogues as antimalarial agents.
Sinha M; Dola VR; Soni A; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
Bioorg Med Chem; 2014 Nov; 22(21):5950-60. PubMed ID: 25284252
[TBL] [Abstract][Full Text] [Related]
35. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
Stewart LB; Peters W; Robinson BL
Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
[TBL] [Abstract][Full Text] [Related]
36. [The blood schizontocidal effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on mice infected with Plasmodium berghei].
Ye XY; Shao BR; Chu YH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(2):120-3. PubMed ID: 1394908
[TBL] [Abstract][Full Text] [Related]
37. Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.
Nuralitha S; Siregar JE; Syafruddin D; Hoepelman AIM; Marzuki S
Malar J; 2017 May; 16(1):216. PubMed ID: 28535797
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis.
Dutta GP; Bajpai R; Vishwakarma RA
Pharmacol Res; 1989; 21(4):415-9. PubMed ID: 2771860
[TBL] [Abstract][Full Text] [Related]
39. Selection of Plasmodium yoelii nigeriensis resistant to triple drug combination (sulphadoxine/pyrimethamine/mefloquine) and its response to other antimalarials.
Shukla B; Bajpai R; Dutta GP
Indian J Malariol; 1988 Jun; 25(1):1-6. PubMed ID: 3266603
[No Abstract] [Full Text] [Related]
40. The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials.
Peters W; Fleck SL; Robinson BL; Stewart LB; Jefford CW
Ann Trop Med Parasitol; 2002 Sep; 96(6):559-73. PubMed ID: 12396319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
